Stereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Best Practice & Research in Clinical Gastroenterology

• Publication date

  2016-08-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/J.BPG.2016.06.003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

  2018cited by this paper
• Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

  2016cited by this paper
• Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.

  2016cited by this paper
• Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases.

  2016influential reference
• Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients

  2016cited by this paper
• Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

  2016cited by this paper
• Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy.

  2015cited by this paper
• Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.

  2015cited by this paper
• Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.

  2015cited by this paper
• Liver regeneration following repeat SBRT.

  2015cited by this paper
• Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma

  2015cited by this paper
• Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis.

  2015cited by this paper
• Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies

  2015cited by this paper
• A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

  2015cited by this paper
• Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer

  2015cited by this paper
• Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma

  2015cited by this paper
• Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery.

  2015cited by this paper
• Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.

  2014cited by this paper
• Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma.

  2014cited by this paper
• Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients

  2014cited by this paper
• Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma

  2014cited by this paper
• Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma

  2014cited by this paper
• The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence‐based comparison and review

  2014cited by this paper
• Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma

  2014cited by this paper
• Local Control Following Stereotactic Body Radiotherapy for Liver Tumors: A Preliminary Report of the AAPM Working Group for SBRT

  2014cited by this paper
• Clinical practice guidelines: Management of Hepatocellular Carcinoma

  2014cited by this paper
• Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.

  2013cited by this paper
• Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity

  2013cited by this paper
• Two‐week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma

  2013cited by this paper
• Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT).

  2013cited by this paper
• Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma

  2013cited by this paper
• High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities

  2013cited by this paper
• Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases

  2013cited by this paper
• Transarterial Chemoembolization in Combination with Local Therapies for Hepatocellular Carcinoma: A Meta-Analysis

  2013cited by this paper
• Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial.

  2013cited by this paper
• Brief introduction to 2012 EASL-EORTC Clinical Practice Guidelines on the management of hepatocellular carcinoma

  2012cited by this paper
• Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization

  2012cited by this paper
• Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation.

  2012cited by this paper
• Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma

  2012cited by this paper
• Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

  2012cited by this paper
• Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.

  2012cited by this paper
• Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: Evaluation of radiological and pathological response

  2012cited by this paper
• Phase I Study of Sorafenib and SBRT for Advanced Hepatocellular Carcinoma

  2012cited by this paper
• Long‐term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation

  2012cited by this paper
• Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship?

  2011cited by this paper
• Risk of HBV Reactivation According to Viral Status and Treatment Intensity in Patients with Hepatocellular Carcinoma

  2011cited by this paper
• Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases

  2011cited by this paper
• Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience.

  2011cited by this paper
• Stereotactic body radiotherapy for primary hepatocellular carcinoma.

  2011cited by this paper
• Stereotactic body radiotherapy for colorectal liver metastases

  2011cited by this paper
• Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma

  2010cited by this paper
• Stereotactic body radiotherapy for unresectable cholangiocarcinoma.

  2010cited by this paper
• Hypofractionated Stereotactic Body Radiotherapy for Primary and Metastatic Liver Tumors Using the Novalis Image-Guided System: Preliminary Results regarding Efficacy and Toxicity

  2010cited by this paper
• Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma

  2010cited by this paper
• Stereotactic body radiation therapy for colorectal liver metastases

  2010cited by this paper
• Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.

  2010cited by this paper
• Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma

  2010cited by this paper
• Stereotactic fractionated radiotherapy for Klatskin tumours.

  2010cited by this paper
• Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its use

  2010cited by this paper
• Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results

  2010cited by this paper
• Frameless single-session robotic radiosurgery of liver metastases in colorectal cancer patients.

  2010cited by this paper
• Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

  2010cited by this paper
• Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.

  2009cited by this paper
• Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results.

  2009cited by this paper
• Phase I study of individualized stereotactic body radiotherapy of liver metastases.

  2009cited by this paper
• Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.

  2009cited by this paper
• Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors.

  2008cited by this paper
• Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

  2008cited by this paper
• Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma.

  2007cited by this paper
• Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.

  2006cited by this paper
• Phase II study on stereotactic body radiotherapy of colorectal metastases

  2006cited by this paper
• Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

  2006cited by this paper
• Stereotactic radiotherapy of primary liver cancer and hepatic metastases

  2006cited by this paper
• A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.

  2005cited by this paper
• Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.

  2004cited by this paper
• American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy.

  2004cited by this paper
• Analysis of radiation-induced liver disease using the Lyman NTCP model.

  2002cited by this paper
• Ethnic differences in the behavior of hepatocellular carcinoma

  1999cited by this paper
• Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model.

  1998cited by this paper
• Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects.

  1994cited by this paper
• Tolerance of normal tissue to therapeutic irradiation.

  1991cited by this paper
• The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study.

  1978cited by this paper

• Hybrid 3D T1-weighted gradient-echo sequence for fiducial marker detection and tumor delineation via magnetic resonance imaging in liver stereotactic body radiation therapy.

  2022cites this paper
• Stereotactic body radiation therapy in patients with liver oligometastases from colorectal cancer: a systematic review

  2022cites this paper
• Basics of Ablative Radiotherapy: The Background Knowledge Necessary to Practicing Stereotactic Body Radiotherapy for Hepatocellular Carcinoma

  2021cites this paper
• Radiomics for liver tumours

  2020cites this paper
• Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group

  2020cites this paper
• Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma

  2020cites this paper
• Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases.

  2019cites this paper
• Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma.

  2019cites this paper
• Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.

  2019cites this paper
• Evaluation of a commercial automatic treatment planning system for liver stereotactic body radiation therapy treatments.

  2018cites this paper
• The role of albumin–bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy

  2018cites this paper
• Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors

  2018cites this paper
• Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis

  2018cites this paper
• Repeated SBRT for in- and out-of-field recurrences in the liver

  2018cites this paper
• Surgical Management of Hilar Cholangiocarcinoma

  2018cites this paper
• Stereotactic body radiotherapy for patients with hepatocellular carcinoma and intermediate grade cirrhosis - Authors' reply.

  2017cites this paper
• Alternate Fractionation for Hepatic Tumors

  2017cites this paper
• Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

  2017cites this paper
• Update on current problems in colorectal liver metastasis.

  2017cites this paper